LifePoint Health (NASDAQ:LPNT) announced its quarterly earnings results on Friday. The company reported $0.77 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.04), Bloomberg Earnings reports. LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same period last year, the firm earned $1.07 earnings per share. LifePoint Health’s revenue was down 7.2% on a year-over-year basis. LifePoint Health updated its FY18 guidance to $4.00-4.53 EPS.
Shares of LifePoint Health (LPNT) opened at $42.75 on Friday. LifePoint Health has a 1-year low of $41.45 and a 1-year high of $67.95. The company has a quick ratio of 1.65, a current ratio of 1.85 and a debt-to-equity ratio of 1.24. The company has a market cap of $1,685.03, a PE ratio of 17.38, a PEG ratio of 0.98 and a beta of 0.52.
LPNT has been the subject of a number of research reports. Credit Suisse Group initiated coverage on shares of LifePoint Health in a research report on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 price target for the company. BidaskClub raised shares of LifePoint Health from a “strong sell” rating to a “sell” rating in a research report on Friday, December 15th. Leerink Swann reissued an “outperform” rating and issued a $58.00 price target (down from $74.00) on shares of LifePoint Health in a research report on Tuesday, October 31st. They noted that the move was a valuation call. Goldman Sachs Group initiated coverage on shares of LifePoint Health in a research report on Wednesday, January 3rd. They issued a “sell” rating and a $45.00 price target for the company. Finally, ValuEngine cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. One equities research analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $58.13.
Institutional investors have recently modified their holdings of the company. Cerebellum GP LLC acquired a new position in shares of LifePoint Health during the fourth quarter worth about $126,000. State of Alaska Department of Revenue acquired a new position in shares of LifePoint Health during the fourth quarter worth about $134,000. US Bancorp DE increased its stake in shares of LifePoint Health by 62.4% during the fourth quarter. US Bancorp DE now owns 3,095 shares of the company’s stock worth $155,000 after acquiring an additional 1,189 shares during the period. Xact Kapitalforvaltning AB acquired a new position in shares of LifePoint Health during the fourth quarter worth about $230,000. Finally, Parametrica Management Ltd acquired a new position in shares of LifePoint Health during the third quarter worth about $282,000.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://sportsperspectives.com/2018/02/25/lifepoint-health-lpnt-announces-earnings-results-misses-expectations-by-0-04-eps.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.